• Portrait of Julian Kim.
  • Assistant professor

    Max Rady College of Medicine
    University of Manitoba
    GA216 – 820 Sherbrook Street
    Health Sciences Centre
    Winnipeg, Manitoba R3E 0W2

    Phone: 204-787-4760
    Fax: 204-787-2080


  • Department of Radiation Oncology, CancerCare Manitoba

Research summary

Dr. Kim’s research focuses on the development, operation and analysis of phase 2 and phase 3 investigator-initiated clinical trials in oncology geared towards improving cure rates, reducing treatment related toxicity, or detecting cancer early so that it can be managed better. He currently has prospective clinical trials in prostate, lung cancer, breast cancer and esophageal cancer which are testing interventions such as metformin in high risk prostate cancer and high-precision real-time radiofrequency guidance techniques for stereotactic body radiotherapy of moving lung tumours. Dr. Kim has developed knowledge translation projects aimed at increasing the sustainable use of radiotherapy resources with the Canadian Partnership Against Cancer. Dr. Kim also has an interest in breast cancer risk assessment and prevention through lifestyle modification and the use of preventative medications.

  • Research interests 

    • Real-time radiofrequency transponder guided stereotactic body radiotherapy
    • Prevention of metabolic complications of androgen deprivation therapy
    • Radioimmunotherapy for esophageal cancer
    • Breast cancer risk prediction with polygenic risk scores
    • Knowledge translation in radiation oncology
    • Non-invasive early detection of lung cancer
  • Research groups and affiliations

    • Affiliate scientist, Research Institute in Oncology and Hematology, CancerCare Manitoba and UM
    • Canadian Cancer Trial Group – Genitourinary Disease Site Trial Development Committee
    • Canadian Partnership Against Cancer
    • George & Fay Yee Center for Healthcare Innovation
  • Research themes 

    • Investigator-initiated clinical trials
    • Stereotactic body radiotherapy
    • Pharmacoepidemiology
    • Risk prediction modelling
    • Early cancer detection
    • Knowledge translation
  • Keywords

    • Phase II clinical trials
    • Investigator-initiated clinical trials
    • Stereotactic body radiotherapy
    • Androgen deprivation therapy
    • Polygenic risk scores
    • Radiofrequency transponder guidance
    • Non-invasive lung cancer early detection


Dr. Kim is a clinician-scientist and radiation oncologist at CancerCare Manitoba with a cross appointment to the radiology department of the Max Rady College of Medicine. His clinical duties include the care of cancer patients with lung, breast, prostate and esophgeal cancers. His desire to improve treatment outcomes for the patients he serves inspires the development of his clinical trials. Dr. Kim is originally from Winnipeg, Manitoba and previously trained and worked as a chemical engineer and Maritime Surface Officer in the Royal Canadian Navy. Dr. Kim is married with three children. 

  • Education

    Masters of Clinical Epidemiology, University of Alberta (2014)

    Doctor of Medicine, University of Manitoba (2007)

    Bachelor of Chemical and Materials Engineering, Royal Military College of Canada (2001)

  • Awards

    Alberta Advanced Education Graduate Student Scholarship (2014)

    Michael J Hutchison Research Fellowship Award; Alberta Cancer Foundation (2012-2014)

Contact us

Room GA216, 820 Sherbrook Street
University of Manitoba
Winnipeg, MB R3T 2N2 Canada